In Vivo Pharmacokinetics and Pharmacodynamics of a New Triazole, Voriconazole, in a Murine Candidiasis Model

Ítems similars

• In Vivo Pharmacodynamics of a New Triazole, Ravuconazole, in a Murine Candidiasis Model
  per: Andes, D., et al.
  Publicat: (2003)
• In Vivo Pharmacodynamics of HMR 3270, a Glucan Synthase Inhibitor, in a Murine Candidiasis Model
  per: Andes, D., et al.
  Publicat: (2003)
• Pharmacodynamics of a New Triazole, Posaconazole, in a Murine Model of Disseminated Candidiasis
  per: Andes, D., et al.
  Publicat: (2004)
• In Vivo Pharmacokinetics and Pharmacodynamics of the Lantibiotic NAI-107 in a Neutropenic Murine Thigh Infection Model
  per: Lepak, Alexander J., et al.
  Publicat: (2015)
• In Vivo Characterization of the Pharmacodynamics of Flucytosine in a Neutropenic Murine Disseminated Candidiasis Model
  per: Andes, D., et al.
  Publicat: (2000)